Evidence map›Paper›PMID 36855368›Full record

ArticleVeterinary world2023

Chicken

Rifky Rizkiantino, Fachriyan Hasmi Pasaribu, Retno Damajanti Soejoedono, Wyanda Arnafia, Dinda Reisinta, Rifaldi Iqbal Yadiansyah, Beni Halalludin, Yunita Ardini, Granita Khanaria, I Wayan Teguh Wibawan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary world, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Rifky RizkiantinoDivision of Medical Microbiology, Department of Infectious Animal Diseases and Veterinary Public Health, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia.
Fachriyan Hasmi PasaribuDivision of Medical Microbiology, Department of Infectious Animal Diseases and Veterinary Public Health, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia.
Retno Damajanti SoejoedonoDivision of Medical Microbiology, Department of Infectious Animal Diseases and Veterinary Public Health, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia.
Wyanda ArnafiaDivision of Research and Development, Tekad Mandiri Citra Co., Bandung, Indonesia.
Dinda ReisintaDivision of Research and Development, Tekad Mandiri Citra Co., Bandung, Indonesia.
Rifaldi Iqbal YadiansyahUndergraduate Program of Applied Biology, Department of Biology, Faculty of Mathematics and Natural Sciences, University of Lampung, Bandar Lampung, Indonesia.
Beni HalalludinDepartment of Central Laboratory, Division of Central Laboratory and Disease Research Center, Technology and Research Development, Central Proteina Prima (CP Prima) Inc., Tangerang, Indonesia.
Yunita ArdiniDepartment of Central Laboratory, Division of Central Laboratory and Disease Research Center, Technology and Research Development, Central Proteina Prima (CP Prima) Inc., Tangerang, Indonesia.
Granita KhanariaDepartment of Central Laboratory, Division of Central Laboratory and Disease Research Center, Technology and Research Development, Central Proteina Prima (CP Prima) Inc., Tangerang, Indonesia.
I Wayan Teguh WibawanDivision of Medical Microbiology, Department of Infectious Animal Diseases and Veterinary Public Health, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia.
IPB University · IDPublic Risk Management Association · USSeva Mandir · INLampung University · IDUniversitas Prima Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Streptococcosis is a common bacterial disease in red tilapia, in which Materials and Methods: We conducted a 28-day study for immunoprophylaxis and immunotherapy, each using four groups with two replications: Healthy control fish (KS), non-IgY pellets (PA and TA), pellets with 25% egg yolk containing Results: The pellet with 50% egg yolk with an IgY at 2.43 mg/g pellet, 3% of body weight once daily, was the best formula on experimental fish. The administration of this formulation can also increase non-specific immunity and the distribution of MMCs in the spleen and liver with a survival rate of 55% for 14 days of challenge period in the immunoprophylaxis study and 70% for 21 days of therapy period in the immunotherapy study. Conclusion: Immunoglobulin Y can be a prophylactic and therapeutic agent against streptococcal infections caused

Indexed as

Enterococcus faecalisimmunoglobulin Yimmunoprophylaxisimmunotherapyred tilapiastreptococcal infection

Identifiers

PMID36855368
PMCPMC9967709
OpenAlexW4318323741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.